1. Home
  2. OFG vs LQDA Comparison

OFG vs LQDA Comparison

Compare OFG & LQDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OFG
  • LQDA
  • Stock Information
  • Founded
  • OFG 1964
  • LQDA 2004
  • Country
  • OFG United States
  • LQDA United States
  • Employees
  • OFG N/A
  • LQDA N/A
  • Industry
  • OFG Major Banks
  • LQDA Biotechnology: Pharmaceutical Preparations
  • Sector
  • OFG Finance
  • LQDA Health Care
  • Exchange
  • OFG Nasdaq
  • LQDA Nasdaq
  • Market Cap
  • OFG 1.9B
  • LQDA 1.7B
  • IPO Year
  • OFG N/A
  • LQDA 2018
  • Fundamental
  • Price
  • OFG $44.80
  • LQDA $26.84
  • Analyst Decision
  • OFG Buy
  • LQDA Strong Buy
  • Analyst Count
  • OFG 3
  • LQDA 10
  • Target Price
  • OFG $46.67
  • LQDA $31.40
  • AVG Volume (30 Days)
  • OFG 219.0K
  • LQDA 3.2M
  • Earning Date
  • OFG 10-15-2025
  • LQDA 08-12-2025
  • Dividend Yield
  • OFG 2.68%
  • LQDA N/A
  • EPS Growth
  • OFG 4.40
  • LQDA N/A
  • EPS
  • OFG 4.25
  • LQDA N/A
  • Revenue
  • OFG $619,470,000.00
  • LQDA $19,322,000.00
  • Revenue This Year
  • OFG N/A
  • LQDA $190.73
  • Revenue Next Year
  • OFG $1.89
  • LQDA $421.01
  • P/E Ratio
  • OFG $10.55
  • LQDA N/A
  • Revenue Growth
  • OFG N/A
  • LQDA 30.20
  • 52 Week Low
  • OFG $33.15
  • LQDA $8.75
  • 52 Week High
  • OFG $47.66
  • LQDA $28.00
  • Technical
  • Relative Strength Index (RSI)
  • OFG 62.26
  • LQDA 74.95
  • Support Level
  • OFG $42.56
  • LQDA $26.47
  • Resistance Level
  • OFG $43.51
  • LQDA $27.88
  • Average True Range (ATR)
  • OFG 0.80
  • LQDA 1.44
  • MACD
  • OFG 0.16
  • LQDA 0.35
  • Stochastic Oscillator
  • OFG 98.61
  • LQDA 87.08

About OFG OFG Bancorp

OFG Bancorp is a financial holding company, through its subsidiaries provides banking and financial services. It operates through three segments namely Banking, Wealth Management, and Treasury. It serves to clients such as commercial, consumer, auto, and mortgage lending, checking and savings accounts, financial planning, insurance, financial services, and investment brokerage, and corporate and individual trust and retirement services. The company derives maximum revenue from Banking Segment. It provides services in the region of Puerto Rico.

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.

Share on Social Networks: